Position
Chief Financial Officer
Company
CytoDyn
VancouverBiotechnologyHealthcareHealth CareTherapeuticsDescription
CytoDyn Inc. has announced the appointment of Robert E. Hoffman as Chief Financial Officer, effective May 15, 2025
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AEON Biopharma Appoints Rob Bancroft as Chief Executive Officer (April 22, 2025)
- Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer (April 17, 2025)
- Madrigal Pharmaceuticals Appoints David Soergel as Chief Medical Officer (April 16, 2025)
- Wave Life Sciences Appoints Christopher Wright as Chief Medical Officer (May 28, 2025)
- Inhibikase Therapeutics Appoints David McIntyre as Chief Financial Officer (April 14, 2025)
- TuHURA Appoints Bertrand Le Bourdonnec as Executive Vice President (April 7, 2025)
Who to call at CytoDyn, and when
A new leader at CytoDyn brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CytoDyn raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CytoDyn, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CytoDyn. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CytoDyn changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CytoDyn changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.